Efficacy and safety of intravenous thrombolysis with alteplase for treating acute ischemic stroke at different time windows: A protocol for systematic review and meta-analysis

BACKGROUND: As the priority drug for treating acute ischemic stroke (AIS), alteplase is a thrombolytic drug with strong fibrin specificity. It can obviously treat AIS with high safety. However, the validity of its time window is controversial. This study focus on the efficacy and safety of intraveno...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Baogang, Qian, Fang, Fan, Xijun, Guan, Shaoyong, Zheng, Yan, Yang, Junsu, Xu, Fengming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769329/
https://www.ncbi.nlm.nih.gov/pubmed/33350738
http://dx.doi.org/10.1097/MD.0000000000023620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769329/
https://www.ncbi.nlm.nih.gov/pubmed/33350738
http://dx.doi.org/10.1097/MD.0000000000023620

Ejemplares similares